Chronic obstructive pulmonary disease and ischemic heart disease comorbidity: overview of mechanisms and clinical management.
about
Comorbid Influences on Generic Health-Related Quality of Life in COPD: A Systematic ReviewRisk factors for adverse cardiac events in hip fracture patients: an analysis of NSQIP data.Improving outcomes in chronic obstructive pulmonary disease: the role of the interprofessional approach.Ischemic heart disease among subjects with and without chronic obstructive pulmonary disease--ECG-findings in a population-based cohort study.β-blocker Therapy is Not Associated with Reductions in Angina or Cardiovascular Events After Coronary Artery Bypass Graft Surgery: Insights from the IMAGINE Trial.Should a prolonged duration of dual anti-platelet therapy be recommended to patients with diabetes mellitus following percutaneous coronary intervention? A systematic review and meta-analysis of 15 studies.A potential marker of bare metal stent restenosis: monocyte count - to- HDL cholesterol ratioThe prognostic value of measurement of high-sensitive cardiac troponin T for mortality in a cohort of stable chronic obstructive pulmonary disease patientsTicagrelor induced systemic inflammatory response syndrome.Comorbidity as a contributor to frequent severe acute exacerbation in COPD patients.A minor but deadly surgery of colonic polypectomy in an elderly and fragile patient: a case report and the review of literature.Increased risk of community-acquired pneumonia in COPD patients with comorbid cardiovascular disease.Antiplatelet Treatment Reduces All-Cause Mortality in COPD Patients: A Systematic Review and Meta-Analysis.Long-term hypoxia exposure enhanced IGFBP-3 protein synthesis and secretion resulting in cell apoptosis in H9c2 myocardial cells.Management of Chronic Obstructive Pulmonary Disease in Patients with Cardiovascular Diseases.Chronic Obstructive Pulmonary Disease and Cardiac Diseases. An Urgent Need for Integrated Care.Amino terminal pro brain natriuretic peptide predicts all-cause mortality in patients with chronic obstructive pulmonary disease: Systematic review and meta-analysis.The potential role of endothelial dysfunction and platelet activation in the development of thrombotic risk in COPD patients.Hidden in Plain Sight: Lung Impairment in Ischemic Heart Disease.Patients with symptoms and characteristics consistent with obstructive sleep apnea are at a higher risk for acute and subacute stent thrombosis after percutaneous coronary stent implantation: a single-center case-control study.Assessing the extent of drug interactions among patients with multimorbidity in primary and secondary care in the West Midlands (UK): a study protocol for the Mixed Methods Multimorbidity Study (MiMMS).Impact of acute exacerbations on platelet reactivity in chronic obstructive pulmonary disease patients.Multidimensional approach for the proper management of a complex chronic patient with chronic obstructive pulmonary disease.Therapeutic effects of the combination of inhaled beta2-agonists and beta-blockers in COPD patients with cardiovascular disease.Acute volume loading exacerbates direct ventricular interaction in a model of COPD.Angiotensin-(1-7) attenuated long-term hypoxia-stimulated cardiomyocyte apoptosis by inhibiting HIF-1α nuclear translocation via Mas receptor regulation.
P2860
Q24288655-334F60C6-DECE-4B61-A82B-CE0F9A272EB4Q30981714-07EBEA54-06E2-4151-B52A-61B7CA5B6733Q35821928-2A06D8E1-CDD3-4FC9-ABEB-435BF95DD6D4Q35861330-D232BF30-B9AA-4E52-879B-2259513F4F57Q35907989-A9AF1D37-C460-4BBB-B399-74443B525128Q36117653-62E5C7FC-DD9D-4CE6-88F7-C8A397689DCFQ36156543-CEFF0D7D-20F2-4B98-9BD7-F83995894307Q36204236-0D8E4FE1-6CAA-4BBC-99F0-E55FD78D236EQ36240716-1A21D843-AB77-42AD-88BB-259A98E7BFE0Q37158368-21CDD715-B3DD-41D4-A799-C7885AAE852DQ37286182-4FB9A8BD-EDC3-442A-88E4-DFB0FA9F878CQ37488835-6E5EFA22-8744-4350-A59A-38E7AB4D05B5Q38672259-00492DB8-642C-4931-B043-BC8C45252B24Q38837884-08A0E498-BD46-4FC3-ABEE-FFA0F8D46C62Q38871993-A2B58507-5F18-4B10-BD4B-3F1AB183443BQ38944856-37E4CC7B-9C1D-4833-8544-BDA148EF42A0Q39036840-AC9F1C42-69F5-4043-B2E2-CD5BB0AD970EQ39426025-3BF1802E-93A6-474E-884E-AE30F1AF1E2BQ41115713-1398092A-6F71-4F64-A51C-7E1E806EB242Q41460685-63A3ADF7-0E85-4BB3-B07A-1DB441F2D036Q42125414-A0CE70BC-5F9E-465D-B80F-ED0EA92709E6Q47654408-03EFE5EE-60CF-4F94-8576-3991ADB56A15Q47680491-1F1AA83D-35F6-4EC5-A130-04C038249868Q47792766-271F31A0-ED4D-4EB1-B8B5-72C9E5FA0DC2Q47826393-D35FD357-8AB0-4455-9CC9-A2F83BA8EAB3Q51534336-D07B00C7-E11B-471B-90C7-AA9E3D146FD0
P2860
Chronic obstructive pulmonary disease and ischemic heart disease comorbidity: overview of mechanisms and clinical management.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh
2015年學術文章
@zh-hant
name
Chronic obstructive pulmonary ...... nisms and clinical management.
@en
type
label
Chronic obstructive pulmonary ...... nisms and clinical management.
@en
prefLabel
Chronic obstructive pulmonary ...... nisms and clinical management.
@en
P2093
P2860
P50
P1476
Chronic obstructive pulmonary ...... nisms and clinical management.
@en
P2093
Marco Contoli
Michele Malagù
Susanna Mascetti
P2860
P304
P356
10.1007/S10557-014-6569-Y
P577
2015-04-01T00:00:00Z